
ABVC BioPharma Achieves $150K Milestone in Licensing Strategy, Total Revenue Reaches $846K
ABVC BioPharma's receipt of a $150,000 milestone payment from AiBtl BioPharma underscores the success of its licensing-first strategy, contributing to a total of $846,000 in non-dilutive revenue and highlighting the potential of its CNS-focused botanical therapeutics.
Read full story



























